New Horizons Medical Appoints Dr. Ximena Sanchez as Chief Medical Officer (CMO)

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

FRAMINGHAM, MA / ACCESS Newswire / January 21, 2025 / New Horizons Medical (NHM), a leader in healthcare for dually diagnosed patients with Substance Use Disorders (SUD), behavioral, and mental health challenges, is thrilled to announce the appointment of Dr. Ximena Sanchez as its new Chief Medical Officer (CMO), effective January 15, 2025.

Dr. Sanchez brings a wealth of experience to NHM, with a storied career spanning inpatient and outpatient settings. Her educational background is exemplary, having earned her M.D. from Javeriana University Medical School in Bogota, Colombia, and completing her Psychiatry residency at the Mayo Clinic in Rochester, Minnesota. She further specialized by completing the Harvard Addiction Psychiatry Fellowship at Massachusetts General Hospital, McLean Hospital, and Brigham and Women’s Hospital. Dr. Sanchez is also board-certified in both Psychiatry and Addiction Psychiatry.

With over two decades of experience, Dr. Sanchez has held pivotal leadership roles as medical director at an inpatient detoxification and stabilization facilities. Her vast expertise encompasses patient care, research, and teaching, including a part-time appointment as a former Instructor at Harvard Medical School.

“We are excited to welcome Dr. Sanchez to the New Horizons Medical leadership team,” said Zoser Mohamed, CEO of New Horizons Medical. “Her extensive experience and unwavering dedication to improving patients’ lives make her an exceptional choice to drive our mission of providing outstanding care for those living with SUD, behavioral, and mental health conditions.”

Dr. Sanchez’s leadership will play a vital role in advancing NHM’s mission to provide compassionate, high-quality care that addresses the unique needs of its diverse patient population. She will oversee medical operations, guide clinical excellence, and spearhead innovative initiatives to improve patient outcomes.

For more information about Dr. Sanchez, visit her LinkedIn profile: Dr. Ximena Sanchez LinkedIn.

About New Horizons Medical: New Horizons Medical is a trusted leader in healthcare for patients with complex needs, specializing in treating individuals with Substance Use Disorders (SUD), behavioral, and mental health conditions. With a commitment to innovative care and a compassionate approach, NHM serves communities across Massachusetts through its network of clinics and dedicated medical professionals.

Media Contact:
Zoser Mohamed, MSc., MBA
CEO

New Horizons Medical
info@newhorizonsmedical.org
888-999-2041

SOURCE: New Horizons Medical, Inc.

View the original press release on ACCESS Newswire

Staff

Recent Posts

Bay Area Cognitive Behavioral Therapy Center Expands Treatment Offerings with Acceptance and Commitment Therapy

Bay Area Therapy Center Expand Treatment Options Offering Comprehensive Mental Health Services in San FranciscoSAN…

10 hours ago

Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New…

10 hours ago

Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance

The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of…

1 day ago

ZEISS Shapes the Future of Metrology with Cutting-Edge Technologies Revealed at Event

ZEISS Industrial Quality Solutions will host its first-ever digital launch event for the USA and…

1 day ago

The OhmX RAMP UP Grant Awarded to 15 Laboratories to Advance Genomic Research

PROVIDENCE, R.I., Feb. 21, 2025 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys) and Hitachi High-Tech America,…

1 day ago